Explore the challenges and opportunities in translational research across Asia in this 56-minute panel discussion from the Milken Institute. Gain insights into overcoming the "Valley of Death" in biomedical innovation, improving research capacity, and incentivizing investments. Learn about successful financing models and hear from industry experts on topics such as patient-centric drug development, regulatory environments, data science in medicine, and the economic impact of biomedical research. Discover how countries like China are implementing regulatory reforms and fostering innovation in the pharmaceutical industry. Understand the differences between Asian and European approaches to translational research, and examine the role of patient advocacy in shaping the future of healthcare in the region.
Asia's Next Frontier - Building Capabilities for Translational Research
Overview
Syllabus
Introduction
What is Translational Research
Who does Translational Research
Challenges of Translational Research
The Harrington Project
Focus on Basic Science
Funding Alignment
Focus on Commercial Value
Differences between Asia and Europe
Patient advocacy in Asia
Patient centric drug development
Patient centric translational research
Regulatory environment
Data environment
Clinical trials infrastructure
Medical records
Data assets
Biomedical research as an economic investment
Regulatory reforms in China
Innovation in China
AstraZeneca in China
Access to medicine in China
Data science expertise
AI in drug development
Who pays for the data
Conclusion
Taught by
Milken Institute
